share_log

加科思-B:自願公告 加科思宣佈其P53 Y220C激活劑JAB-30300新藥臨床實驗申請(IND)在美國獲批

JACOBIO-B: VOLUNTARY ANNOUNCEMENT JACOBIO RECEIVED US FDA INVESTIGATIONAL NEW DRUG CLEARANCE FOR P53 Y220C Activator JAB-30300

香港交易所 ·  Feb 29 23:09
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more